MVMD Progress Update

Dear friends of MVMD. I hope this message finds you well and that you are enjoying the warm summer weather.

This morning, we sent out a media release providing a progress update across MVMD’s three main lines of business. You can read the full release on our website at MVMD.com.

As I outline in the release, the past six months has been a transformative window for MVMD and our extensive partner network as we see the differentiation and positive reception of our technologies in the marketplace.

A few notable callouts:

• Our nutraceutical formulation work has expanded to numerous products, and we are actively supporting business development work with full manufacturing capability.
  
  
• Our recent sleep study confirmed measurable data around the effectiveness of MVMD’s Quicksome™ technology applied to the Eons Deeper Sleep product, indicating superior benefits of longer sleep duration, more REM sleep, more deep sleep, and included one hundred percent of participants improving their overall sleep score.
  
  
• Our recent agreement with Agrarius Corp. for exclusivity in Canada, USA, Mexico, South America, Central America, and the Caribbean enabled us to pursue intentional avenues for investment and growth without having to navigate the complexity of additional Agrarius™ sales channel competitors and this has proven to be very fruitful in our advancement of our agricultural line of business.
  
  
• Our agronomists have been working with certified third-party agricultural partners and academic institutions, conducting extensive studies on Agrarius™ treated plants, including enzyme regulation, chlorophyll production, and overall crop health and yields under reduced fertilizer and pesticide conditions across various crop trials. The initial third-party reports are very positive in supporting the numerous benefits to Agrarius™ treated plants vs. control groups.
  
  
• Strong Agrarius™ registration progress with the product now officially saleable in all of the European Union, 44 states in the USA, Canada, and notably approval in Brazil (one of the largest agricultural markets in the world and where we have an advanced business development trialing pipeline with some of the top agricultural players in the world).
  
  
• Agrarius™ has received import approval for Colombia on July 19, 2024, and anticipates receiving the final government approval early this month.
  
  
• Additional Agrarius™ registration approvals anticipated through the remainder of the year include: Panama, Costa Rica, Peru, Uruguay, and Mexico.
  
  
• We have filed for Agrarius™ trademark protection for Brazil, Mexico, Chile, Colombia, Uruguay, Panama, Costa Rica, Peru, Ecuador, Argentina, Paraguay, and Bolivia.
  
  
• The Agrarius™ Performance Guarantee Program inventory for Canada and the USA is being marketed to potential clients for immediate application to eligible crops or by way of purchase order commitments for early spring 2025 crop applications. MVMD has contracted with farming clients under the program who are applying Agrarius™ on corn, russet potatoes, faba beans, wheat, barley, and canola crops.
  
  
• We have deployed a global Agrarius™ brand update, including a focus on developing internationalization into our website strategy to present market-specific content in the user’s native/preferred language based on locale. This includes the development of a primary Agrarius™ brand positioning video asset to support business development in English, Spanish and Portuguese languages (you can check out the branding and new video asset at increasecropyields.com ).
  
  
• Our licensee who is managing the implementation of the Soluvec™ 1% husbandry animal applications in Bangladesh has updated that they have contracted with five distributors in Bangladesh and plan to distribute Soluvec™ 1% coated standard fish feed for farmed fish species in the third quarter this year.

As you can see, our team has been working very hard across each of our lines of business and I am very proud of the work that has been accomplished. Scaling our operations and expanding our strategic partnerships across a broad distribution territory is no small feat and critical to supporting our objective of creating long-term shareholder value.

Thank you for your continued support of our work. As always, please reach out if you have any questions – info@mvmd.com. MVMD continues to do great and important work as we focus on advancing our positive global impact on human, plant and animal health.